Day Pitney has announced the expansion of its intellectual property and technology practice group with the addition of three new members in its Boston office. Christopher Cowles and Richard Emmons have joined the firm as partners, while Erica Fishel has taken on the role of an associate. This strategic move bolsters Day Pitney’s capabilities in the burgeoning field of life sciences patent law.
Christopher Cowles brings with him significant expertise, particularly in the biotechnology sector. He is known for his work with nucleic acid therapeutics, immunotherapy, genomics, and personalized medicine, providing comprehensive services including patent preparation, prosecution, intellectual property due diligence, portfolio management, and freedom-to-operate analyses. Cowles’ experience positions him to effectively counsel both biotechnology companies and academic clients in these highly specialized areas.
Richard Emmons serves clients by offering guidance on global patent strategies and managing intellectual property portfolios. He is experienced in the preparation and prosecution of patent applications, performing freedom-to-operate analyses, and leading due diligence processes for a wide range of clients, including public and private companies, family offices, and investors. His addition to the team enhances Day Pitney’s offerings in the realm of international patent management.
Erica Fishel’s role as an associate further strengthens the team, as she joins a robust practice committed to navigating the complexities of intellectual property law for clients engaged in the life sciences industries.
For more details on Day Pitney’s strategic expansion and insights into these professionals’ achievements, visit the announcement provided by Day Pitney.